GEODE CAPITAL MANAGEMENT, LLC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 65 filers reported holding OVID THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,611,542
+15.9%
1,200,777
-1.0%
0.00%
Q2 2023$3,978,918
+208.7%
1,213,085
+142.8%
0.00%
Q1 2023$1,289,058
+138657.6%
499,6350.0%0.00%
Q4 2022$929
-99.9%
499,635
+1.5%
0.00%
Q3 2022$905,000
-13.8%
492,073
+0.7%
0.00%
Q2 2022$1,050,000
-32.3%
488,436
-1.1%
0.00%
Q1 2022$1,550,000
-15.9%
493,858
-13.9%
0.00%
Q4 2021$1,842,000
-0.5%
573,861
+4.2%
0.00%
Q3 2021$1,851,000
+5.1%
550,902
+22.3%
0.00%
Q2 2021$1,761,000
-42.6%
450,524
-41.0%
0.00%
Q1 2021$3,070,000
+132.6%
763,837
+33.6%
0.00%
Q4 2020$1,320,000
-59.6%
571,734
+0.3%
0.00%
-100.0%
Q3 2020$3,271,000
-24.5%
569,918
-3.0%
0.00%0.0%
Q2 2020$4,331,000
+394.4%
587,758
+99.9%
0.00%
Q1 2020$876,000
-63.3%
294,037
-48.9%
0.00%
Q4 2019$2,388,000
+224.9%
575,858
+153.6%
0.00%
Q3 2019$735,000
+75.0%
227,0420.0%0.00%
Q2 2019$420,000
+7.7%
227,042
+2.9%
0.00%
Q1 2019$390,000
-15.6%
220,688
+15.1%
0.00%
Q4 2018$462,000
-8.9%
191,730
+114.3%
0.00%
Q3 2018$507,000
-15.8%
89,474
+15.8%
0.00%
Q2 2018$602,000
+70.5%
77,288
+54.5%
0.00%
Q1 2018$353,000
+5.4%
50,019
+47.3%
0.00%
Q4 2017$335,000
+15.5%
33,949
+0.1%
0.00%
Q3 2017$290,000
-0.7%
33,899
+21.8%
0.00%
Q2 2017$292,00027,8420.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TLS Advisors LLC 1,380,346$3,51618.08%
Madison Avenue Partners, LP 3,104,603$8,009,8761.72%
BVF INC/IL 6,851,051$17,675,7120.65%
CHI Advisors LLC 864,822$2,231,2410.59%
EcoR1 Capital, LLC 6,117,400$15,782,8920.51%
Rubric Capital Management LP 7,001,124$18,062,9000.47%
Artal Group S.A. 2,500,000$6,4500.38%
Tejara Capital Ltd 118,791$306,4810.16%
DCF Advisers, LLC 68,264$176,1200.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 827,580$2,135,1560.06%
View complete list of OVID THERAPEUTICS INC shareholders